FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/082152 [Registered on: 11/03/2025] Trial Registered Prospectively
Last Modified On: 10/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Preventive 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effect of Ayurvedic Medicine in Anxiety  
Scientific Title of Study   Randomized Controlled Trail Of Jivaniya Gan Dravya Vati In Ojakshaya With Special Reference To Generalised Anxiety Disorder 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Meerabai Tatyarao 
Designation  PG scholar 
Affiliation  Siddhakala Ayurved mahavidyalaya ,sangamner  
Address  OPD number 1, Kayachikitsa department,Siddhakala Ayurved mahavidyalaya, Pimparne road ,sangamner Ahemdnagar, Maharashtra,422605

Ahmadnagar
MAHARASHTRA
422605
India 
Phone  7020484805  
Fax    
Email  lambemeera108@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Vd Omkar Vinayak Kortikar 
Designation  HOD of Department of Kayachikitsa 
Affiliation  Siddhakala Ayurved Mahavidyalaya, Sangamner 
Address  Kayachikitsa department Siddhakala Ayurveda mahavidyalaya,Pimparne Road,sangamner

Ahmadnagar
MAHARASHTRA
422605
India 
Phone  9850218004  
Fax    
Email  omkar_kortikar@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Vd Omkar Vinayak Kortikar 
Designation  HOD of Department of Kayachikitsa 
Affiliation  Siddhakala Ayurved Mahavidyalaya, Sangamner 
Address  Kayachikitsa department Siddhakala Ayurveda mahavidyalaya,Pimparne Road,sangamner

Ahmadnagar
MAHARASHTRA
422605
India 
Phone  9850218004  
Fax    
Email  omkar_kortikar@yahoo.com  
 
Source of Monetary or Material Support  
siddhakala ayurved mahavidyalay,Pimparne road,sangamner Khurd,Sangamner,Ahilyanagar,Maharashtra,422605 
 
Primary Sponsor  
Name  Meerabai Tatyarao 
Address  Siddhakala ayurved mahavidyalay,Pimparne road ,Sangamner khurd,Sangamner,Ahamadnagar,Maharashtra,India.Pincode-422605 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Meerabai Tatyarao  Siddhakala ayurved Mahavidyalaya, sangamner  OPD number 1, Kayachikitsa department, Siddhakala Ayurved mahavidyalaya, Pimparne road , sangamnner Ahmadnagar, MAHARASHTRA
Ahmadnagar
MAHARASHTRA 
7020484805

lambemeera108@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Board of Ayurved Research and Statistics Committee of Siddhakala Ayurved Mahavidyalaya,Sangamner  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:F411||Generalized anxiety disorder. Ayurveda Condition: OJAKSHAYAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Jivaniya Gan Dravya Vati, Reference: Ashtanga Hridaya Samhita,Sutra Sthan, ,Chapter number 11,Shloka number 41, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -Godugdha), Additional Information: -Aushadh Sevan Kaala-VyanoUdan Kala,Anupaan Matra 5 to 10 ml
2Comparator ArmDrugClassical(1) Medicine Name: Jatamansi Vati , Reference: Bhavprakash Nighantu, Karpuradi Varga, Jatamansi , Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -Koshna Jal), Additional Information: -Aushadha Sevan Kala - Vyanoudana
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients up to Moderate level of Anxiety below 14 points on GAD 7 Scales,Patient having lakshnas of Ojakshaya.  
 
ExclusionCriteria 
Details  Patient taking psychotropic drugs four weeks prior to study,Substance abuse like Alcohol,Pregnant and Lactating Mothers,Patients with Ischemic Heart Disease,Hypertension,Myocardial Infarction,Cerebrovascular event,Cardiac arrythmias,Diabetes and active Malignant disease. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To evaluate the efficacy of Oral administration of 500 mg Jivaniya Gan Dravya Vati twice a day with Godugdha 5 to 10 ml for 30 days in managment of Ojakshay with special reference to Generalised Anxiety Disorder Based on diffrence in Parameters of GAD 7 scale and DSM v criteria assessed before and after treatment   10 th day 
 
Secondary Outcome  
Outcome  TimePoints 
To conceptually study the Ojakshya & its management by relevant ancient methodology.
To observe the adverse effect of Jivaniya Gan Dravya Vati in Ojakshaya if any.
To asses any correlation between Oja & Generalised Anxiety Disorder 10 Edit || Delete
 
10 th day 
 
Target Sample Size   Total Sample Size="74"
Sample Size from India="74" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   03/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is Randomized Open labelled Controlled Clinical Trail Comparing The Safety and Efficacy Of Jivaniya Gan Dravya Vati 500 mg and Controlled Drug Jatamansi Vati 500 mg for 30 days in 74 patient With Generalised Anxiety Disorder and effect on  Generalised Anxiety Disorder 7 Scale . 
Close